To view this email as a web page, click here.

In this issue of Dermatology Times, we focus on key presentations from the American Academy of Dermatology annual meeting held last month in San Diego.
 
Dermatology Times cover
AAD insights and takeaways
In this article, Dr. Norman Levine sums up his takeaways from the American Academy of Dermatology annual meeting, beginning with a presentation by two physicians who addressed the difficulties of managing hidradenitis suppurativa, such as fixed dosing. He also addressed controversies associated with treatments for atopic dermatitis. Apparently, bleach baths are no better than regular baths in improving skin symptoms.
Learn more.
 
The promise of biologic therapy in dermatology
During the American Academy of Dermatology’s annual meeting, physicians addressed the monumental changes that have occured since the advent of biologic therapy for systemic autoimmune conditions, such as psoriasis and atopic dermatitis. Today, some patients are able to achieve complete disease clearance. Although there may be viable treatments for these conditions, access to care and medication adherence remain top issues, physicians say.
Learn more.
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.